XML 114 R89.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Payment (Details) - Schedule of stock options activities - Stock options [Member]
 12 Months Ended
Jun. 30, 2021
USD ($)
$ / shares
shares
Share-Based Payment (Details) - Schedule of stock options activities [Line Items]  
Number of stock options Outstanding at beginning (in Shares) | shares 988,932
Weighted Average Exercise Price Outstanding at beginning $ 3.38
Weighted Average Grant-date Fair Value Outstanding at beginning $ 1.56
Weighted Average Remaining Contractual Life Outstanding at beginning 5 years 4 months 24 days
Aggregate Intrinsic Value Outstanding at beginning (in Dollars) | $
Number of stock options Granted (in Shares) | shares 618,839
Weighted Average Exercise Price Granted $ 2.68
Weighted Average Grant-date Fair Value Granted $ 1.04
Weighted Average Remaining Contractual Life Granted
Aggregate Intrinsic Value Granted (in Dollars) | $
Number of stock options Exercised (in Shares) | shares (61,328) [1]
Weighted Average Exercise Price Exercised $ 3.95 [1]
Weighted Average Grant-date Fair Value Exercised $ 2.04 [1]
Weighted Average Remaining Contractual Life Exercised [1]
Aggregate Intrinsic Value Exercised (in Dollars) | $ [1]
Number of stock options Forfeited or expired (in Shares) | shares (115,953)
Weighted Average Exercise Price Forfeited or expired $ 2.93
Weighted Average Grant-date Fair Value Forfeited or expired $ 1.19
Weighted Average Remaining Contractual Life Forfeited or expired
Aggregate Intrinsic Value Forfeited or expired (in Dollars) | $
Number of stock options Outstanding at end (in Shares) | shares 1,430,490
Weighted Average Exercise Price Outstanding at end $ 3.09
Weighted Average Grant-date Fair Value Outstanding at end $ 1.35
Weighted Average Remaining Contractual Life Outstanding at end 4 years 4 months 24 days
Aggregate Intrinsic Value Outstanding at end (in Dollars) | $ $ 1,949,145
Number of stock options Outstanding and exercisable (in Shares) | shares 255,165
Weighted Average Exercise Price Outstanding and exercisable $ 3.83
Weighted Average Grant-date Fair Value Outstanding and exercisable $ 1.91
Weighted Average Remaining Contractual Life and exercisable
Aggregate Intrinsic Value Outstanding and exercisable (in Dollars) | $ $ 228,723
Number of stock options Vested and expected to vest (in Shares) | shares 1,231,149
Weighted Average Exercise Price Vested and expected to vest $ 3.19
Weighted Average Grant-date Fair Value Vested and expected to vest $ 0.29
Weighted Average Remaining Contractual Life Vested and expected to vest 4 years 4 months 24 days
Aggregate Intrinsic Value Vested and expected to vest (in Dollars) | $ $ 1,595,418
[1] During year ended June 30, 2021, 61,328 share options were exercised and 49,704 common shares were issued.